Top Markets
Coin of the day
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Corporation

NYMX
Rank in Stocks #23483
Nymox Pharmaceutical Corporation operates as a biopharmaceutical firm,... Nymox Pharmaceutical Corporation operates as a biopharmaceutical firm, primarily focused on the discovery and advancement of medications for the aging population across Canada, the United States, Europe, and other international regions. The company's leading experimental compound is Fexapotide Triflutate (NX-1207), which has successfully concluded Phase III clinical trials for benign prostatic hyperplasia treatment. It has also completed Phase II trials for localized low-grade prostate cancer and is currently in preclinical studies for hepatocellular carcinoma. In addition to its drug pipeline, Nymox develops and markets diagnostic products. These include NicAlert and TobacAlert, tests that utilize urine or saliva samples to identify the use of tobacco products. The company further offers AlzheimAlert, a proprietary urine-based assay designed to aid healthcare professionals in diagnosing Alzheimer's disease. Alongside this diagnostic tool, Nymox is actively researching and developing therapeutic treatments for Alzheimer's disease. Founded in 1989, the company is headquartered in Nassau, the Bahamas.
Share Price
$0.977
Last synced: 2023-08-11
Market Cap
$72.98M
Change (1 day)
4.94%
Change (1 year)
0.00%
Country
BS
Trade Nymox Pharmaceutical Corporation (NYMX)

Category

Stock price history for Nymox Pharmaceutical Corporation (NYMX)
Highest end of day price: $0.99 on 2023-08-01

Lowest end of day price: $6.33 on 1997-11-01
Stock price history of Nymox Pharmaceutical Corporation from 1997 to 2026
Annual Stock Price Performance
Year Performance
2023 151.39%
2022 -66.65%
2021 -48.99%
2020 9.87%
2019 34.83%
2018 -54.85%
2017 16.78%
2016 -15.16%
2015 708.48%
2014 -93.14%
2013 -9.25%
2012 -13.68%
2011 50.92%
2010 17.92%
2009 47.20%
2008 -48.95%
2007 74.88%
2006 62.86%
2005 -26.81%
2004 -2.76%
2003 -25.35%
2002 1.15%
2001 147.59%
2000 -46.71%
1999 -43.98%
1998 -24.06%
1997 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH